Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  days prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Patients must not have an active infection requiring oral or IV antibiotics within  days prior to registration; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to Cycle , Day . Participants receiving prophylactic antibiotics (for prevention of a urinary tract infection chronic obstructive pulmonary disease) are eligible
Therapeutic oral or intravenous (IV) antibiotics within  weeks prior to first day of study treatment:\r\n* Patients receiving prophylactic antibiotics (eg, to prevent a urinary tract infection or chronic obstructive pulmonary disease exacerbation) are eligible
GENERAL: Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day .\r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible.
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to start of study treatment.\r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible.
Received therapeutic oral or IV antibiotics within  weeks prior to first day of study treatment:\r\nPatients receiving prophylactic antibiotics (eg, to prevent a urinary tract infection or chronic obstructive pulmonary disease exacerbation) are eligible
Treatment with therapeutic oral or IV antibiotics within  days prior to initiation of study treatment; patients receiving prophylactic antibiotics (e.g. for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to study treatment; but patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day  a) Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received therapeutic oral or IV antibiotics within  week prior to cycle  day \r\n* Subjects receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or to prevent chronic obstructive pulmonary disease exacerbation) are eligible
Received oral or IV antibiotics =<  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Patients who have received oral or IV antibiotics within  weeks before initiation of study treatment; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day  (Patients receiving prophylactic antibiotics [e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease] are eligible.)
Received oral or IV antibiotics within  weeks prior to week , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Treatment with therapeutic oral or IV antibiotics within  weeks prior to initiation of study treatment; patients receiving prophylactic antibiotics (e.g., to prevent a urinary tract infection or chronic obstructive pulmonary disease exacerbation) are eligible for the study
Received therapeutic oral or IV antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Therapeutic oral or IV antibiotics within  weeks prior to cycle , day \r\n* Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or to prevent chronic obstructive pulmonary disease exacerbation) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or intravenous (IV) antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received oral or IV antibiotics within  weeks prior to cycle , day  for treatment of active infection (patients receiving prophylactic antibiotics [e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease] are eligible)
Patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received IV antibiotics within  weeks prior to cycle , day ; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
Received therapeutic oral or intravenous (IV) antibiotics within  weeks prior to first day of study treatment; patients receiving prophylactic antibiotics (e.g., to prevent a urinary tract infection or chronic obstructive pulmonary disease exacerbation) are eligible
